Document And Entity Information
Document And Entity Information - shares | 3 Months Ended | |
Mar. 31, 2023 | May 12, 2023 | |
Document Information Line Items | ||
Entity Registrant Name | Wright Investors Service Holdings, Inc. | |
Trading Symbol | IWSH | |
Document Type | 10-Q | |
Current Fiscal Year End Date | --12-31 | |
Entity Common Stock, Shares Outstanding | 20,620,711 | |
Amendment Flag | false | |
Entity Central Index Key | 0001279715 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Document Period End Date | Mar. 31, 2023 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q1 | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | true | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity File Number | 000-50587 | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 13-4005439 | |
Entity Address, Address Line One | 118 North Bedford Road | |
Entity Address, Address Line Two | Ste. 100 | |
Entity Address, City or Town | Mount Kisco | |
Entity Address, State or Province | NY | |
Entity Address, Postal Zip Code | 10549 | |
City Area Code | (914) | |
Local Phone Number | 242-5700 | |
Entity Interactive Data Current | Yes | |
Title of 12(g) Security | Common Stock, $0.01 par value | |
Security Exchange Name | NONE |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Current assets | ||
Cash and cash equivalents | $ 103 | $ 90 |
Investments in U.S. Treasury Bills | 3,871 | 4,130 |
Income tax receivable | 73 | 73 |
Prepaid expenses and other current assets | 68 | 100 |
Total current assets | 4,115 | 4,393 |
Other assets | 8 | 8 |
Total assets | 4,123 | 4,401 |
Current liabilities | ||
Accounts payable and accrued expenses | 113 | 112 |
Total current liabilities | 113 | 112 |
Total liabilities | 113 | 112 |
Stockholders’ equity | ||
Preferred stock, par value $0.01 per share, authorized 10,000,000 shares; none issued | ||
Common stock, par value $0.01 per share, authorized 30,000,000 shares; Issued 21,628,680 and 21,343,680 as of March 31, 2023 and December 31, 2022, respectively; Outstanding 20,620,711 and 20,335,711 at March 31, 2023 and December 31, 2022, respectively; 0 and 285,000 shares issuable as of March 31, 2023 and December 31, 2022, respectively | 216 | 213 |
Additional paid-in capital | 34,392 | 34,395 |
Accumulated deficit | (28,918) | (28,604) |
Accumulated other comprehensive income | 67 | 32 |
Treasury stock, at cost (1,007,969 shares at March 31, 2023 and December 31, 2022) | (1,747) | (1,747) |
Total stockholders' equity | 4,010 | 4,289 |
Total liabilities and stockholders’ equity | $ 4,123 | $ 4,401 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares | Mar. 31, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in Dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock, shares issued | ||
Common stock, par value (in Dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 30,000,000 | 30,000,000 |
Common stock, shares Issued | 21,628,680 | 21,343,680 |
Common stock, shares outstanding | 20,620,711 | 20,335,711 |
Common stock, shares issuable | 0 | 285,000 |
Treasury stock, shares | 1,007,969 | 1,007,969 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Expenses | ||
Compensation and benefits | $ 115 | $ 117 |
Other operating | 205 | 197 |
Total operating expenses | 320 | 314 |
Loss from operations | (320) | (314) |
Interest and other income, net | 6 | |
Loss from operations before income taxes | (314) | (314) |
Net loss | $ (314) | $ (314) |
Basic weighted average common shares outstanding (in Shares) | 20,620,711 | 20,490,385 |
Basic loss per share (in Dollars per share) | $ (0.02) | $ (0.02) |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Income Statement [Abstract] | ||
Basic and diluted weighted average common shares outstanding | 20,620,711 | 20,490,385 |
Basic and diluted loss per share | $ (0.02) | $ (0.02) |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Statement of Comprehensive Income [Abstract] | ||
Net loss | $ (314) | $ (314) |
Unrealized gain on available for sale securities | 35 | |
Comprehensive loss | $ (279) | $ (314) |
Condensed Consolidated Statem_4
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands | Common stock (Issued) | Additional paid – in Capital | Accumulated deficit | Accumulated other comprehensive income | Treasury stock, at cost | Total |
Balance at Dec. 31, 2021 | $ 210 | $ 34,316 | $ (27,397) | $ (1,699) | $ 5,430 | |
Balance (in Shares) at Dec. 31, 2021 | 21,025,748 | |||||
Net loss | (314) | (314) | ||||
Equity based compensation expense | $ 1 | 1 | 2 | |||
Equity based compensation expense (in Shares) | 100,000 | |||||
Stock based compensation expense to directors | 20 | 20 | ||||
Stock based compensation expense to directors (in Shares) | ||||||
Balance at Mar. 31, 2022 | $ 211 | 34,337 | (27,711) | (1,699) | 5,138 | |
Balance (in Shares) at Mar. 31, 2022 | 21,125,748 | |||||
Balance at Dec. 31, 2022 | $ 213 | 34,395 | (28,604) | 32 | (1,747) | 4,289 |
Balance (in Shares) at Dec. 31, 2022 | 21,343,680 | |||||
Net loss | (314) | (314) | ||||
Stock based compensation expense to directors | $ 3 | (3) | ||||
Stock based compensation expense to directors (in Shares) | 285,000 | |||||
Other comprehensive income | 35 | 35 | ||||
Balance at Mar. 31, 2023 | $ 216 | $ 34,392 | $ (28,918) | $ 67 | $ (1,747) | $ 4,010 |
Balance (in Shares) at Mar. 31, 2023 | 21,628,680 |
Condensed Consolidated Statem_5
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Cash flows from operating activities | ||
Net loss | $ (314) | $ (314) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Equity based compensation, including vesting of stock to directors | 22 | |
Changes in other operating items: | ||
Prepaid expenses and other current assets | 32 | (6) |
Accounts payable and accrued expenses | 1 | (3) |
Net cash used in operating activities | (281) | (301) |
Cash flows from investing activities | ||
Proceeds from redemptions of U.S. Treasury Bills | 294 | |
Net cash provided by investing activities | 294 | |
Net increase (decrease) in cash and cash equivalents | 13 | (301) |
Cash and cash equivalents at the beginning of the period | 90 | 5,396 |
Cash and cash equivalents at the end of the period | 103 | 5,095 |
Supplemental disclosures of cash flow information | ||
Unrealized gain on available for sale securities | $ 35 |
Basis of presentation and descr
Basis of presentation and description of activities | 3 Months Ended |
Mar. 31, 2023 | |
Basis of presentation and description of activities [Absract] | |
Basis of presentation and description of activities | 1. Basis of presentation and description of activities Basis of presentation The accompanying interim financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. The information and note disclosures normally included in complete financial statements have been condensed or omitted pursuant to such rules and regulations. The Condensed Consolidated Balance Sheet as of December 31, 2022 has been derived from audited financial statements. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2022 as presented in our Annual Report on Form 10-K. In the opinion of management, this interim information includes all material adjustments, which are of a normal and recurring nature, necessary for a fair presentation. The results for the 2023 interim period are not necessarily indicative of results to be expected for the entire year. Description of activities Wright Investors’ Service Holdings, Inc. (the “Company”) has nominal operations and nominal assets aside from its cash and cash equivalents and investments in U.S. Treasury Bills, and is therefore considered a shell company, as defined in U.S. securities laws and regulations. The Company is not engaged in the business of investing, reinvesting, or trading in securities, and it does not hold itself out as being engaged in those activities. The Company intends to evaluate and explore all available strategic options. The Company will continue to work to maximize stockholder value. Such strategic options may include acquisition of an investment advisory business, acquisition of a financial services business, creating partnerships or joint ventures for those or other businesses and investing in other businesses that provide attractive opportunities for growth. The directors will also consider alternatives for distributing some or all of the Company’s cash and cash equivalents. Until such time as a decision is made as to how the liquid assets of the Company are so deployed, the Company intends to invest its liquid assets in high-grade, short- term investments (such as cash and cash equivalents and Investment in U.S. Treasury Bills) consistent with the preservation of principal, maintenance of liquidity and avoidance of speculation. The Company may be classified as an inadvertent investment company if the Company acquires investment securities in excess of 40% of the Company’s total assets (exclusive of government securities). As of March 31, 2023, the Company is not considered an inadvertent investment company. |
Per share data
Per share data | 3 Months Ended |
Mar. 31, 2023 | |
Earnings Per Share [Abstract] | |
Per share data | 2. Per share data Loss per share for the three months ended March 31, 2023 and 2022, respectively, is calculated based on 20,620,711 and 20,490,385 weighted average outstanding shares of common stock, including weighted average issuable shares of 200,690 at March 31, 2022. |
Investment valuation
Investment valuation | 3 Months Ended |
Mar. 31, 2023 | |
Investment Valuation [Abstract] | |
Investment valuation | 3. Investment valuation The Company carries its investments at fair value. Fair value is an estimate of the exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants (i.e., the exit price at the measurement date). Fair value measurements are not adjusted for transaction costs. A fair value hierarchy provides for prioritizing inputs to valuation techniques used to measure fair value into three levels: Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 Inputs other than quoted market prices that are observable, either directly or indirectly, and reasonably available. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the Company. Level 3 Unobservable inputs. Unobservable inputs reflect the assumptions that the Company develops based on available information about what market participants would use in valuing the asset or liability. An asset or liability's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 or Level 2 assets or liabilities. As of March 31, 2023 and December 31, 2022, the Company held $3,871,000 and $4,130,000, respectively, in U.S. government debt securities. U.S. government securities are valued using a model that incorporates market observable data, such as reported sales of similar securities, broker quotes, yields, bids, offers, and reference data. Certain securities are valued principally using dealer quotations. Money market funds are valued at the closing price reported by the fund sponsor from an actively traded exchange. U.S. government debt securities are categorized in Level 2 of the fair value hierarchy, depending on the inputs used and market activity levels for specific securities. The U.S. government debt securities, which have maturities of three months or less at time of purchase , are reported as Cash and cash equivalents, and those with longer maturities are reported as investments, on the condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022. Short-term investments in marketable securities have a stated maturity of twelve months or less from the balance sheet date. These securities are considered as available for sale and are reported at fair value. Unrealized gains and losses would be recorded net of tax as a component of Accumulated other comprehensive income within stockholders' equity. Declines in market value from the original cost deemed to be "other-than-temporary" are charged to Interest and other income, net, in the period in which the loss occurs. The Company considers both the duration for which a decline in value has occurred and the extent of the decline in its determination of whether a decline in value has been “other than temporary.” Realized gains and losses are calculated based on the specific identification method and are included in Interest and other income, net, in the condensed consolidated statement of operations. The following table presents the Company’s financial instruments at fair value (in thousands): Fair Value Measurements as of March 31, 2023 3/31/2023 Quoted Prices Significant Significant Investments in U.S. Treasury bills $ 3,871 $ - $ 3,871 $ - Fair Value Measurements as of December 31, 2022 12/31/2022 Quoted Prices Significant Significant Investments in U.S. Treasury bills $ 4,130 $ - $ 4,130 $ - Investments in debt securities as of March 31, 2023 are summarized by type below (in thousands). Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value U.S. Treasury bills $ 3,804 $ 67 $ - $ 3,871 Total $ 3,804 $ 67 $ - $ 3,871 All investments in debt securities are due in one year or less as of March 31, 2023. Investments in debt securities as of December 31, 2022 are summarized by type below (in thousands). Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value U.S. Treasury bills $ 4,098 $ 32 $ - $ 4,130 Total $ 4,098 $ 32 $ - $ 4,130 The Company may be exposed to credit losses through its available-for-sale investments. An available-for-sale security is impaired when its fair value declines below its amortized cost basis. Unrealized losses resulting from the amortized cost basis of any available-for-sale debt security exceeding its fair value are evaluated for identification of credit losses. When evaluating the investments for impairment at each reporting period, the Company reviews factors such as the extent of the unrealized loss, historical losses, current and future economic market conditions, and financial condition of the issuer. As of March 31, 2023, the Company has not recognized an allowance for expected credit losses related to its available-for-sale securities as the Company has not identified any unrealized losses for these investments attributable to credit factors. |
Income taxes
Income taxes | 3 Months Ended |
Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income taxes | 4. Income taxes No tax benefit has been recorded in relation to the pre-tax loss for the three months ended March 31, 2023 and 2022, due to a full valuation allowance to offset any deferred tax asset related to net operating loss carry forwards attributable to the losses. |
Capital Stock
Capital Stock | 3 Months Ended |
Mar. 31, 2023 | |
Capital Stock [Abstract] | |
Capital Stock | 5. Capital Stock The Company’s Board of Directors, without any vote or action by the holders of common stock, is authorized to issue preferred stock from time to time in one or more series and to determine the number of shares and to fix the powers, designations, preferences and relative, participating, optional or other special rights of any series of preferred stock. The Board of Directors authorized the Company to repurchase up to 5,000,000 outstanding shares of common stock from time to time either in open market or privately negotiated transactions. On April 5, 2022, in accordance with the Board of Directors’ prior authorization, the Company purchased 192,750 shares of its common stock in a privately negotiated transaction at a price of $0.25 per share for an amount of approximately $48,000. The Company did not repurchase any common stock during the quarter ended March 31, 2023 and 2022. At March 31, 2023, the Company had repurchased 2,234,721 shares of its common stock and a total of 2,765,279 of the authorized shares, remained available for repurchase as of March 31, 2023. At March 31, 2022, the Company had repurchased 2,041,971 shares of its common stock and a total of 2,958,029 of the authorized shares, remained available for repurchase at March 31, 2022. On March 9, 2023, there were 285,000 shares of Company common stock issued to the independent directors of the Company, in payment of quarterly directors’ fees due to them for services in 2022, which were classified as issuable at December 31, 2022. As of March 31, 2022, there were 217,932 shares of Company common stock to be issued to the independent directors of the Company, in payment of quarterly directors’ fees due to them for services in 2021 and the first quarter of 2022. The shares were issued on April 28, 2022. The equity compensation awards were issued pursuant to the exemption from the registration requirements of Section 5 of the Securities Act of 1933 (“1933 Act”) provided by Section 4(a)(2) of the 1933 Act. In March 2023, the Company amended its Directors’ Compensation Program for Directors who are not employees of the Company to provide that effective January 1, 2023 and as long as the Company remains a shell company (i) the issuance of any annual stock compensation for Directors serving as a member of the Board or a committee of the Board shall be terminated, and (ii) the payment of any cash compensation for attendance in person or by telephone of meetings of the Board or committees of the Board shall be terminated. |
Incentive stock plans and stock
Incentive stock plans and stock-based compensation | 3 Months Ended |
Mar. 31, 2023 | |
Incentive stock plans and stock-based compensation [Abstract] | |
Incentive stock plans and stock-based compensation | 6. Incentive stock plans and stock-based compensation Stock awards On February 13, 2019, 100,000 stock awards were issued to a newly appointed director of the Company. The stock awards vest equally, annually, over 3 years. The stock awards are valued based on the closing price of $0.42 of the Company’s common stock on February 13, 2019. At March 31, 2023, all shares had vested and were issued. The Company recorded compensation expense of $0 and approximately $1,750 for each of the three months ended March 31, 2023 and 2022, respectively, related to those stock awards. There was no unrecognized compensation expense related to these unvested stock awards at March 31, 2023. Common stock options The Company adopted a stock-based compensation plan for employees and non-employee members of its Board of Directors in November 2003 (the “2003 Plan”), and the National Patent Development Corporation 2007 Incentive Stock Plan in December 2007 (the “2007 NPDC Plan”). The periods during which additional awards may be granted under the plans have expired and no further awards may be granted under any of these plans after December 20, 2017. As a consequence, any equity compensation awards issued after that time will be on terms determined by the Board of Directors or the Compensation Committee of the Board of Directors and pursuant to exemptions from the registration requirements of the securities laws. As of March 31, 2022, all options were vested and there were no outstanding options under the 2007 NPDC Plan. There were no grants, forfeitures or exercises of options during the three months ended March 31, 2022 or 2023. |
Investment valuation (Tables)
Investment valuation (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Investment Valuation [Abstract] | |
Schedule of financial instruments at fair value | Fair Value Measurements as of March 31, 2023 3/31/2023 Quoted Prices Significant Significant Investments in U.S. Treasury bills $ 3,871 $ - $ 3,871 $ - Fair Value Measurements as of December 31, 2022 12/31/2022 Quoted Prices Significant Significant Investments in U.S. Treasury bills $ 4,130 $ - $ 4,130 $ - |
Schedule of investments in debt securities | Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value U.S. Treasury bills $ 3,804 $ 67 $ - $ 3,871 Total $ 3,804 $ 67 $ - $ 3,871 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value U.S. Treasury bills $ 4,098 $ 32 $ - $ 4,130 Total $ 4,098 $ 32 $ - $ 4,130 |
Per share data (Details)
Per share data (Details) - shares | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Earnings Per Share [Abstract] | ||
Weighted average outstanding shares of common stock | 20,620,711 | 20,490,385 |
Weighted average issuable shares | 200,690 |
Investment valuation (Details)
Investment valuation (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
US Government Debt Securities [Member] | ||
Investment valuation (Details) [Line Items] | ||
U.S. government debt securities | $ 3,871,000 | $ 4,130,000 |
Investment valuation (Details)
Investment valuation (Details) - Schedule of financial instruments at fair value - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Derivatives, Fair Value [Line Items] | ||
Investments in U.S. Treasury bills | $ 3,871 | $ 4,130 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Derivatives, Fair Value [Line Items] | ||
Investments in U.S. Treasury bills | ||
Significant Other Observable Inputs (Level 2) | ||
Derivatives, Fair Value [Line Items] | ||
Investments in U.S. Treasury bills | 3,871 | 4,130 |
Significant Unobservable Inputs (Level 3) | ||
Derivatives, Fair Value [Line Items] | ||
Investments in U.S. Treasury bills |
Investment valuation (Details_2
Investment valuation (Details) - Schedule of investments in debt securities - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 | Dec. 31, 2022 | |
Investment valuation (Details) - Schedule of investments in debt securities [Line Items] | ||
Amortized Cost | $ 3,804 | $ 4,098 |
Gross Unrealized Gains | 67 | 32 |
Gross Unrealized Losses | ||
Fair Value | 3,871 | 4,130 |
U.S. Treasury bills [Member] | ||
Investment valuation (Details) - Schedule of investments in debt securities [Line Items] | ||
Amortized Cost | 3,804 | 4,098 |
Gross Unrealized Gains | 67 | 32 |
Gross Unrealized Losses | ||
Fair Value | $ 3,871 | $ 4,130 |
Capital Stock (Details)
Capital Stock (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |||
Apr. 05, 2022 | Mar. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2022 | |
Capital Stock (Details) [Line Items] | ||||
Authorized number of shares to be repurchased | 5,000,000 | |||
Number of shares repurchased | 192,750 | 2,234,721 | 2,041,971 | |
Transaction price per share (in Dollars per share) | $ 0.25 | |||
Transaction amount (in Dollars) | $ 48,000 | |||
Remaining number of shares available for repurchase | 2,765,279 | 2,958,029 | ||
Common stock to be issued | 285,000 | |||
Director [Member] | ||||
Capital Stock (Details) [Line Items] | ||||
Common stock to be issued | 217,932 |
Incentive stock plans and sto_2
Incentive stock plans and stock-based compensation (Details) - Newly appointed director [Member] - USD ($) | 1 Months Ended | 3 Months Ended | |
Feb. 13, 2019 | Mar. 31, 2023 | Mar. 31, 2022 | |
Incentive stock plans and stock-based compensation (Details) [Line Items] | |||
Stock awards were issued (in Shares) | 100,000 | ||
Stock Awards [Member] | |||
Incentive stock plans and stock-based compensation (Details) [Line Items] | |||
Vesting period | 3 years | ||
Stock awards closing price (in Dollars per share) | $ 0.42 | ||
Compensation expense | $ 0 | $ 1,750 |